Delivery Order SPE2DB22D3501-SPE2DB24FVQ36

Award Date 5/10/24
Potential Completion Date 5/13/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,193.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of sevelamer 0.8 gram powder packets. The contract does not have a set-aside designation, indicating an open competition. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and...
This federal contract award is for the delivery of 4,563,773,873 units of Sevelamer 0.8 gram powder packets in lots of 90 to the Defense Logistics Agency. The total potential value of the award is $1,534.84. The contract is a firm fixed price delivery order with a completion date of February 27, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical sourcing and distribution company. The contract does not have a...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,394.11, is for the delivery of sevelamer carbonate 800 mg tablets to support military healthcare programs. This is a delivery order contract with a firm fixed price pricing type, with a period of performance ending on January 2, 2024. The contract was awarded on December 29, 2023 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $2,090.40 firm fixed price delivery order is for the supply of 4,564,235,475 units of Sevelamer Carbonate 800 mg tablets in 270-count packages. The contract has an ultimate completion date of April 11, 2024. In addition to this specific delivery order, AmerisourceBergen Drug Corp holds a larger indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sevelamer Carbonate 800 mg tablets, a medication used to treat certain health conditions. The contract has a ceiling value of $4,170 and a period of performance through February 28, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation indicated....
This federal contract award, SPE2DB22D1017|SPE2DB25FF1VF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,646.06 Firm Fixed Price delivery order is for the supply of 4566777153 SEVELAMER CARBONATE 800 MG TAB 270S, a medical product. The contract has an ultimate completion date of December 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This contract award to AmerisourceBergen Drug Corp's Corporate Office Division provides for the delivery of sevelamer carbonate 800 mg tablets to the Department of Defense's Medical Supply Chain (DLA Troop Support Medical). The $2,192.13 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract valued at up to $999,999,999 through December 2025 for pharmaceutical and medical supplies. This contract does not have a set-aside designation. AmerisourceBergen, one of the...
This federal contract award, valued at $6,580.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,067,259 units of sevelamer carbonate 800 mg tablets, with a completion date of July 5, 2024. Amerisourcebergen is a major pharmaceutical distribution company that has been awarded numerous federal contracts to supply a wide range of prescription drugs, over-the-counter medications, and medical...
This is a $5,318.73 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 270 tablets of Sevelamer Carbonate 800 mg, a medication used to manage high phosphorus levels in patients with chronic kidney disease. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,167.53, is for the delivery of 270 tablets of the drug Renvela 800 mg. The contract is a firm-fixed-price delivery order, with a period of performance through May 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVQ36
    Delivery Order

This federal contract award, with ID SPE2DB22D3501|SPE2DB24FVQ36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,440.95, is for the delivery of sevelamer 2.4 GM powder packets.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:14 PM